Abstract 5373: Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer.
jianhua luo,ying ding,rui chen,george k michalopoulos,joel b nelson,george c tseng,yan p yu
DOI: https://doi.org/10.1158/1538-7445.AM2013-5373
IF: 11.2
2013-01-01
Cancer Research
Abstract:Altered genome methylation is a hallmark of human malignancies. To investigate the global methylation profile of prostate cancer, high-throughput analysis of concordant methylation and gene expression events was carried out for 124 human prostate specimens, including prostate cancer (T), normal adjacent to tumor (AT), and organ donor (OD). Methylated DNA in genomic DNA was immunoprecipitated with anti-methylcytidine antibodies, amplified by adaptor-specific priming PCR, and detected by Affymetrix human whole genome SNP 6.0 chips. Pair-wise analyses of methylation-enriched DNA, along with the matched genome copy number analysis of the same samples, were performed to determine the differential DNA methylation profiles of the T, AT and OD samples. A total of 34,413 methylated genome segments were identified. Among these, 11,481 CpG islands were found in the promoter and exon 1 regions of 9,295 genes. Seven-thousand-six-hundred-forty-one genes were found to be methylated frequently across the OD, AT and T samples, while 239 genes were found to be differentially methylated in only T and 785 genes were methylated in both AT and T but not OD. Genes with promoter methylation and concordant suppressed expression were identified by the pair analyses of T/OD, AT/OD, and T/AT. Pathway analysis suggested that many of the methylated genes in T and AT had cell growth and mitogenic functions. Classification analysis of the differentially methylated genes in T or OD produced a specificity of 89.4% and a sensitivity of 85.7%. The T and AT groups, on the other hand, were only slightly separated by the prediction analysis, indicating a strong field effect. A gene methylation prediction model was developed using the methylation status of 20 genes, and was shown to predict prostate cancer relapse with a sensitivity of 80.0% and a specificity of 85.0%. Collectively, these results suggest methylation patterns may be useful predictive markers of prostate cancer clinical outcomes. Citation Format: Jian-Hua Luo, Ying Ding, Rui Chen, George K. Michalopoulos, Joel B. Nelson, George C. Tseng, Yan P. Yu. Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 5373. doi:10.1158/1538-7445.AM2013-5373 Note: This abstract was not presented at the AACR Annual Meeting 2013 because the presenter was unable to attend.